Literature DB >> 7014594

Gonadal autoantibodies in patients with hypogonadism and/or Addison's disease.

M Elder, N Maclaren, W Riley.   

Abstract

The sera from 325 normal individuals, 21 patients with Turner's syndrome, 505 patients with insulin-dependent diabetes mellitus, 15 patients with unexplained ovarian insufficiency, and 37 patients with Addison's disease or serological evidence of adrenal autoimmunity were examined for the presence of gonadal autoantibodies by an indirect immunofluorescent technique using sections of human testis. All 12 patients found to have gonadal autoantibodies also had adrenocortical autoantibodies. These autoantibodies were completely absorbed with powdered adrenal cortex and thus were "steroidal cell" antibodies (SCA), cross-reactive with a cytosolic antigen in the steroid-producing cells of adrenal cortex, placental syncytiotrophoblast, Leydig areas of testis, and theca interna/granulosa layer of ovarian follicles. Sera with SCA had reduced titers of adrenal antibodies after repeated absorptions with gonadal or placental tissues, suggesting that adrenal-specific autoantibodies were also present. Sera from patients with only adrenal antibodies had no significant changes in antibody titers after repeated absorptions with gonadal or placental tissues. In conclusion, all gonadal autoantibodies found were SCA. SCA were only found in patients with adrenal autoimmunity, many of whom had hypogonadism. In other patients or in normal individuals, the existence of SCA or gonadal autoimmunity in the absence of adrenocortical autoantibodies must be rare.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7014594     DOI: 10.1210/jcem-52-6-1137

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Antiovarian antibodies in primary Sjogren's syndrome.

Authors:  Kyriaki Euthymiopoulou; Alexios J Aletras; Panagiota Ravazoula; Anna Niarakis; Dimitris Daoussis; Ioannis Antonopoulos; Stamatis-Nick Liossis; Andrew P Andonopoulos
Journal:  Rheumatol Int       Date:  2007-05-31       Impact factor: 2.631

2.  Premature ovarian failure.

Authors:  R Jewelewicz; M Schwartz
Journal:  Bull N Y Acad Med       Date:  1986-04

Review 3.  Polyglandular autoimmune syndrome: current concepts.

Authors:  J Meyerson; E E Lechuga-Gomez; P E Bigazzi; P G Walfish
Journal:  CMAJ       Date:  1988-04-01       Impact factor: 8.262

Review 4.  Autoimmune Addison's disease.

Authors:  A Muir; D A Schatz; N K Maclaren
Journal:  Springer Semin Immunopathol       Date:  1993

5.  Can anti-ovarian antibody testing be useful in an IVF-ET clinic?

Authors:  Eusebio S Pires; Firuza R Parikh; Purvi V Mande; Shonali A Uttamchandani; Sujata Savkar; Vrinda V Khole
Journal:  J Assist Reprod Genet       Date:  2010-10-12       Impact factor: 3.412

6.  Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum.

Authors:  H Moncayo; R Moncayo; R Benz; A Wolf; C Lauritzen
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease.

Authors:  O Winqvist; J Gustafsson; F Rorsman; F A Karlsson; O Kämpe
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

8.  Detection of antibodies to ovarian antigens in women with premature ovarian failure.

Authors:  N J Wheatcroft; A A Toogood; T C Li; I D Cooke; A P Weetman
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

9.  Organ-specific autoimmunity in patients with premature ovarian failure.

Authors:  L Belvisi; F Bombelli; L Sironi; N Doldi
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

Review 10.  A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency.

Authors:  A Falorni; V Minarelli; C M Eads; C M Joachim; L Persani; R Rossetti; P Yurttas Beim; V A Pellegrini; P F Schnatz; S Rafique; K Kissell; K A Calis; V Popat; L M Nelson
Journal:  Panminerva Med       Date:  2014-10-07       Impact factor: 5.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.